Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL DE PHARMACIEN D'OFFICINE AUBERT : revenue, balance sheet and financial ratios

SPFPL DE PHARMACIEN D'OFFICINE AUBERT is a French company founded 7 years ago, specialized in the sector Activités des sociétés holding. Based in REVEL (31250), this company of category PME shows in 2025 a net income positive of 105 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DE PHARMACIEN D'OFFICINE AUBERT (SIREN 849663562)
Indicator 2025
Revenue N/C
Net income 105 065 €
EBITDA -2 168 €
Net margin N/C

Revenue and income statement

In 2025, SPFPL DE PHARMACIEN D'OFFICINE AUBERT generates positive net income of 105 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 168 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-2 168 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

105 065 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 138%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 6.1 years of cash flow to repay all financial debt. This ratio remains within usual banking standards.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

137.546%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

42.097%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

6.088

Solvency indicators evolution
SPFPL DE PHARMACIEN D'OFFICINE AUBERT

Sector positioning

Debt ratio
137.55 2025
2025
Q1: 0.04
Med: 8.09
Q3: 54.01
Average

In 2025, the debt ratio of SPFPL DE PHARMACIEN D'OFF... (137.55) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
42.1% 2025
2025
Q1: 21.27%
Med: 67.32%
Q3: 92.99%
Average

In 2025, the financial autonomy of SPFPL DE PHARMACIEN D'OFF... (42.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
6.09 years 2025
2025
Q1: 0.0 years
Med: 0.19 years
Q3: 2.98 years
Average

In 2025, the repayment capacity of SPFPL DE PHARMACIEN D'OFF... (6.09) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-127.583

Liquidity indicators evolution
SPFPL DE PHARMACIEN D'OFFICINE AUBERT

Sector positioning

Interest coverage
-127.58x 2025
2025
Q1: -62.1x
Med: 0.0x
Q3: 0.0x
Average

In 2025, the interest coverage of SPFPL DE PHARMACIEN D'OFF... (-127.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Positioning of SPFPL DE PHARMACIEN D'OFFICINE AUBERT in its sector

Comparison with sector Activités des sociétés holding

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (20 transactions). This range of 41 897€ to 1 291 172€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2025
Indicative
41k€ 215k€ 1291k€
215 785 € Range: 41 897€ - 1 291 172€
NAF 5 année 2025
How is this estimate calculated?

This estimate is based on the analysis of 20 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des sociétés holding)

Compare SPFPL DE PHARMACIEN D'OFFICINE AUBERT with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des sociétés holding

Frequently asked questions about SPFPL DE PHARMACIEN D'OFFICINE AUBERT

What is the revenue of SPFPL DE PHARMACIEN D'OFFICINE AUBERT ?

The revenue of SPFPL DE PHARMACIEN D'OFFICINE AUBERT is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL DE PHARMACIEN D'OFFICINE AUBERT profitable?

Yes, SPFPL DE PHARMACIEN D'OFFICINE AUBERT generated a net profit of 105 k€ in 2025.

Where is the headquarters of SPFPL DE PHARMACIEN D'OFFICINE AUBERT ?

The headquarters of SPFPL DE PHARMACIEN D'OFFICINE AUBERT is located in REVEL (31250), in the department Haute-Garonne.

Where to find the tax return of SPFPL DE PHARMACIEN D'OFFICINE AUBERT ?

The tax return of SPFPL DE PHARMACIEN D'OFFICINE AUBERT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DE PHARMACIEN D'OFFICINE AUBERT operate?

SPFPL DE PHARMACIEN D'OFFICINE AUBERT operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.